Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...

The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.